Australia markets open in 47 minutes

aTyr Pharma, Inc. (LIFE)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.6100-0.0900 (-5.29%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 115.50M
Enterprise value 32.43M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)258.16
Price/book (mrq)1.27
Enterprise value/revenue 91.87
Enterprise value/EBITDA -0.62

Trading information

Stock price history

Beta (5Y monthly) 1.23
52-week change 3-11.46%
S&P500 52-week change 321.83%
52-week high 32.7000
52-week low 31.0800
50-day moving average 31.8445
200-day moving average 31.6394

Share statistics

Avg vol (3-month) 3556.42k
Avg vol (10-day) 3367k
Shares outstanding 567.94M
Implied shares outstanding 667.94M
Float 860.12M
% held by insiders 12.62%
% held by institutions 161.82%
Shares short (28 Mar 2024) 4436.89k
Short ratio (28 Mar 2024) 40.62
Short % of float (28 Mar 2024) 40.91%
Short % of shares outstanding (28 Mar 2024) 40.64%
Shares short (prior month 29 Feb 2024) 4108.23k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 301 July 2019
Ex-dividend date 4N/A
Last split factor 21:14
Last split date 301 July 2019

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-15,557.79%

Management effectiveness

Return on assets (ttm)-31.72%
Return on equity (ttm)-62.31%

Income statement

Revenue (ttm)353k
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)-100.00%
Gross profit (ttm)N/A
EBITDA -54.33M
Net income avi to common (ttm)-50.39M
Diluted EPS (ttm)-0.9400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)98.17M
Total cash per share (mrq)1.45
Total debt (mrq)15.1M
Total debt/equity (mrq)16.69%
Current ratio (mrq)6.27
Book value per share (mrq)1.43

Cash flow statement

Operating cash flow (ttm)-33.22M
Levered free cash flow (ttm)-21.18M